---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their solid tumor’s genetic signature into ... Our partnership with NEC ensures that TG4050 is benefitting from its world-leading expertise in artificial intelligence and its unique algorithm that is used to select up to 30 patient-specific antigens that allow ..."
publishedDateTime: 2020-01-07T00:10:00Z
sourceUrl: https://montrealgazette.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/transgene-and-nec-start-two-clinical-trials-with-tg4050-an-ai-powered-cancer-vaccine-for-ovarian-and-head-neck-cancers/wcm/6351875c-17fd-4563-9d64-3ce3bdd5f661
ampUrl: https://montrealgazette.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/transgene-and-nec-start-two-clinical-trials-with-tg4050-an-ai-powered-cancer-vaccine-for-ovarian-and-head-neck-cancers/wcm/6351875c-17fd-4563-9d64-3ce3bdd5f661/amp
cdnAmpUrl: https://montrealgazette-com.cdn.ampproject.org/c/s/montrealgazette.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/transgene-and-nec-start-two-clinical-trials-with-tg4050-an-ai-powered-cancer-vaccine-for-ovarian-and-head-neck-cancers/wcm/6351875c-17fd-4563-9d64-3ce3bdd5f661/amp
type: article
quality: 14
heat: -1
published: false

provider:
  name: Montreal News
  domain: montrealgazette.com

topics:
  - AI
  - AI in Healthcare

related:
  - title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
    excerpt: "\"As each patient's cancer is unique, we have developed a therapy that turns their solid tumor's genetic signature into a ... Our partnership with NEC ensures that TG4050 is benefitting from its world-leading expertise in artificial intelligence and its unique algorithm that is used to select up to 30 patient-specific antigens that allow this ..."
    publishedDateTime: 2020-01-06T23:00:00Z
    sourceUrl: https://www.benzinga.com/pressreleases/20/01/b15081336/transgene-and-nec-start-two-clinical-trials-with-tg4050-an-ai-powered-cancer-vaccine-for-ovarian-a
    ampUrl: https://amp.benzinga.com/amp/content/15081336
    cdnAmpUrl: https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/15081336
    type: article
    provider:
      name: Benzinga.com
      domain: benzinga.com
    quality: 14

secured: "OPTLu79WWqF6/e5Afp9IOUiO55M6kUR343EMp4ojXn1LsWDqoh8s8RgLyrpODXVxWqIlBdN4Fqq7jJubulb/wCQ+pRdFzWlXKLa55cGxaPv5sL77KDIC3V5Lgxp8dZpBpcuUdKYmK0gM770VJDITtFd/r2+KcnblRKhQAppnyiBOaIiZs02pyZiQJiMznh1sd8aFgaIK7ot9c1Wu6iyuIo6ML58cuSGjfzqWJXXOF9J+2N5pVQ0KtFJxUpBn9BwrWj/qYdM7WgeBFh5JiUHPRQ==;cGxxCSDF2IjqqEZvbhdLqw=="
---

